Humoral immunity in xenotransplantation: B-cell tolerance and accommodation

Current Opinion in Organ Transplantation

Volumn 9, Issue 2, 2004, Pages 170-175

  Koch, Cody A ^a   Khalpey, Zain I ^a   Platt, Jeffrey L ^a,b  

^a Mayo Clinic   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

Accommodation; B cells; Complement; Tolerance; Transplantation; Xenotransplantation

Indexed keywords

EID: 33745751036     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/01.mot.0000127677.16900.27     Document Type: Review

References (67)

1. Jaboulay M: De reins au pli du coude par soutures arterielles et veineuses. Lyon Med 1906, 107:575-577.
2. Anonymous: Dr. Hammond gives patient new kidney. N Y Times 1911.
3. Schwartz R, Stack J, Dameshek W: Effect of 6-mercaptopurine on antibody production. Proc Soc Exp Biol Med 1958, 99:164-167.
4. Cooper DK: Clinical xenotransplantation-how close are we? Lancet 2003, 362:557-559.
5. Sachs DH, Sablinski T: Tolerance across discordant xenogeneic barriers. Xenotransplantation 1995, 2:234-239.
6. Platt JL, Vercellotti GM, Dalmasso AP, et al.: Transplantation of discordant xenografts: a review of progress. Immunol Today 1990, 11:450-456.
7. Cascalho M, Platt JL: The immunological barrier to xenotransplantation. Immunity 2001, 14:437-446.
8. Deacon T, Schumacher J, Dinsmore J, et al.: Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson's disease. Nat Med 1997, 3:350-353.
9. Nagata H, Ito M, Cai J, et al.: Treatment of cirrhosis and liver failure in rats by hepatocyte xenotransplantation. Gastroenterology 2003, 124:422-431.
10. Van den Bogaerde J, Aspinall R, Wang M-W, et al.: Induction of long-term survival of hamster heart xenografts in rats. Transplantation 1991, 52:15-20.
11. Leventhal JR, Dalmasso AP, Cromwell JW, et al.: Prolongation of cardiac xenograft survival by depletion of complement. Transplantation 1993, 55:857-866.
12. McCurry KR, Kooyman DL, Alvarado CG, et al.: Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nat Med 1995, 1:423-427.
13. Leventhal JR, Matas AJ, Sun LH, et al.: The immunopathology of cardiac xenograft rejection in the guinea pig-to-rat model. Transplantation 1993, 56:1-8.
14. Lin SS, Weidner BC, Byrne GW, et al.: The role of antibodies in acute vascular rejection of pig-to-baboon cardiac transplants. J Clin Invest 1998, 101:1745-1756.
15. Lin SS, Hanaway MJ, Gonzalez-Stawinski GV, et al.: The role of anti-Galα1- 3Gal antibodies in acute vascular rejection and accommodation of xenografts. Transplantation 2000, 70:1667-1674.
16. Bracy JL, Sachs DH, Iacomini J: Inhibition of xenoreactive natural antibody production by retroviral gene therapy. Science 1998, 281:1845-1847.
17. Bracy JL, Iacomini J: Induction of B-cell tolerance by retroviral gene therapy. Blood 2000, 96:3008-3015.
18. Ogawa H, Mohiuddin MM, Yin DP, et al.: Mouse-heart grafts expressing an incompatible carbohydrate antigen, II: transition from accommodation to tolerance. Transplantation 2004, 77:366-373.
19. Ogawa H, Yin DP, Galili U: Induction of immune tolerance to a transplantation carbohydrate antigen by gene therapy with autologous lymphocytes transduced with adenovirus containing the corresponding glycosyltransferase gene. Gene Ther 2004, 11:292-301.
20. Mohiuddin MM, Ogawa H, Yin DP, et al.: Tolerance induction to a mammalian blood group-like carbohydrate antigen by syngeneic lymphocytes expressing the antigen, II: tolerance induction on memory B cells. Blood 2003, 102:229-236.
21. Miyata Y, Platt J: Xeno: still stuck without a-Gal. Nat Biotechnol 2003, 21:359-360.
22. Hansen AB, Kirkeby S, Aasted B, et al.: The resistance of delayed xenograft rejection to alpha(1,3)-galactosyltransferase gene inactivation and CD4 depletion in a mouse-to-rat model. APMIS 2003, 111:1019-1026.
23. Lai L, Kolber-Simonds D, Park KW, et al.: Production of α-1,3- galactosyltransferase knockout pigs by nuclear transfer cloning. Science 2002, 295:1089-1092.
24. Phelps CJ, Koike C, Vaught TD, et al.: Production of alpha 1,3-galactosyltransferase-deficient pigs. Science 2003, 299:411-414.
25. Yang Y-G, deGoma E, Ohdan H, et al.: Tolerization of anti-Galα1- 3Gal natural antibody-forming B cells by induction of mixed chimerism. J Exp Med 1998, 187:1335-1342.
26. Mohiuddin MM, Qin Y, Qian X, et al.: Long-term survival of cardiac xenografts in fully xenogeneic (mouse → rat) bone marrow chimeras. Ann Thorac Surg 2001, 72:740-745; discussion 745-746.
27. Abe M, Qi J, Sykes M, et al.: Mixed chimerism induces donor-specific T-cell tolerance across a highly disparate xenogeneic barrier. Blood 2002, 99:3823-3829.
28. Knosalla C, Cooper DK: Xenotransplantation and tolerance. Front Biosci 2002, 7:d1280-d1287.
29. Liechty KW, MacKenzie TC, Shaaban AF, et al.: Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med 2000, 6:1282-1286.
30. Ogle BM, Butters KB, Plummer TB, et al.: Spontaneous fusion of cells between species yields transdifferentiation and retroviral in vivo. FASEB J 2004, 18:548-550.
31. Sablinski T, Emery DW, Monroy R, et al.: Long-term discordant xenogeneic (porcine-to-primate) bone marrow engraftment in a monkey treated with porcine- specific growth factors. Transplantation 1999, 67:972-977.
32. Ohdan H, Yang YG, Shimizu A, et al.: Mixed chimerism induced without lethal conditioning prevents T cell- and anti-Gal alpha 1,3Gal-mediated graft rejection. J Clin Invest 1999, 104:281-290.
33. Ohdan H, Swenson KG, Kitamura H, et al.: Tolerization of Gal alpha 1,3Galreactive B cells in pre-sensitized alpha 1,3-galactosyltransferase- deficient mice by nonmyeloablative induction of mixed chimerism. Xenotransplantation 2001, 8:227-238.
34. Ohdan H, Yang YG, Swenson KG, et al.: T cell and B cell tolerance to GALalpha1,3GAL-expressing heart xenografts is achieved in alpha1,3- galactosyltransferase-deficient mice by nonmyeloablative induction of mixed chimerism. Transplantation 2001, 71:1532-1542.
35. Lin Y, Sobis H, Vandeputte M, et al.: Long-term xenograft survival and suppression of xenoantibody formation in the hamster-to-rat heart transplant model using a combination therapy of leflunomide and cyclosporine. Transplant Proc 1994, 26:3202.
36. Lin Y, Sobis H, Vandeputte M, et al.: Induction therapy of leflunomide and cyclosporine allows for long-term xenograft survival under cyclosporine alone. Transplant Proc 1994, 26:3052.
37. Lin Y, Vandeputte M, Waer M: Accommodation and T-independent B cell tolerance in rats with long term surviving hamster heart xenografts. J Immunol 1998, 160:369-375.
38. Chong AS, Shen J, Xiao F, et al.: Delayed xenograft rejection in the concordant hamster heart into Lewis rat model. Transplantation 1996, 62:90-96.
39. Yin D, Ma LL, Blinder L, et al.: Induction of species-specific host accommodation in the hamster-to-rat xenotransplantation model. J Immunol 1998, 161:2044-2051.
40. Tanemura M, Yin D, Chong AS, et al.: Differential immune responses to alphagal epitopes on xenografts and allografts: implications for accommodation in xenotransplantation. J Clin Invest 2000, 105:301-310.
41. Yin D, Ma L, Varghese A, et al.: Intact active bone transplantation synergizes with anti-CD40 ligand therapy to induce B cell tolerance. J Immunol 2002, 168:5352-5358.
42. Buhler L, Awwad M, Basker M, et al.: High-dose porcine hematopoietic cell transplantation combined with CD40 ligand blockade in baboons prevents an induced anti-pig humoral response. Transplantation 2000, 69:2296-2304.
43. Carreno MR, Fuller L, Mathew JM, et al.: Human donor bone marrow cells induce in vitro "suppressor T cells" that functionally suppress autologous B cells. Hum Immunol 2003, 64:21-30.
44. Chen Z, Cobbold S, Metcalfe S, et al.: Tolerance in the mouse to major histocompatibility complex-mismatched heart allografts, and to rat heart xenografts, using monoclonal antibodies to CD4 and CD8. Eur J Immunol 1992, 22:805-810.
45. Chen W, Ford MS, Young KJ, et al.: Role of double-negative regulatory T cells in long-term cardiac xenograft survival. J Immunol 2003, 170:1846-1853.
46. Bannett AD, McAlack RF, Morris M, et al.: ABO incompatible renal transplantation: a qualitative analysis of native endothelial tissue ABO antigens after transplant. Transplant Proc 1989, 21:783-785.
47. Chopek MW, Simmons RL, Platt JL: ABO-incompatible renal transplantation: initial immunopathologic evaluation. Transplant Proc 1987, 19:4553-4557.
48. Koch CA, Khalpey ZI, Platt JL: Accommodation: preventing injury in transplantation and disease. Submitted.
49. Yuzawa Y, Brett J, Fukatsu A, et al.: Interaction of antibody with Forssman antigen in guinea pigs. Am J Pathol 1995, 146:1260-1272.
50. Ulfvin A, Backer AE, Clausen H, et al.: Expression of glycolipid blood group antigens in single human kidneys: change in antigen expression of rejected ABO incompatible kidney grafts. Kidney Int 1993, 44:1289-1297.
51. Parker W, Holzknecht ZE, Song A, et al.: Fate of antigen in xenotransplantation: implications for acute vascular rejection and accommodation. Am J Pathol 1998, 152:829-839.
52. Lin SS, Parker W, Everett ML, et al.: Differential recognition by proteins of α-galactosyl residues on endothelial cell surfaces. Glycobiology 1998, 8:433-443.
53. Gloor JM, Lager DJ, Moore SB, et al.: ABO-incompatible kidney transplantation using both A2 and non-A2 living donors. Transplantation 2003, 75:971-977.
54. Shin ML, Carney DF: Cytotoxic action and other metabolic consequences of terminal complement proteins. Prog Allergy 1988, 40:44-81.
55. Shibata T, Cosio FG, Birmingham DJ: Complement activation induces the expression of decay-accelerating factor on human mesangial cells. J Immunol 1991, 147:3901-3908.
56. Dalmasso AP, Benson BA, Johnson JS, et al.: Resistance against the membrane attack complex of complement induced in porcine endothelial cells with a Gal alpha(1-3)Gal binding lectin: up-regulation of CD59 expression. J Immunol 2000, 164:3764-3773.
57. Dalmasso AP, He T, Benson BA: Human IgM xenoreactive antibodies can induce resistance of porcine endothelial cells to complement-mediated injury. Xenotransplantation 1996, 3:54-62.
58. Grubbs BC, Benson BA, Dalmasso AP: Characteristics of CD59 upregulation induced in porcine endothelial cells by alphaGal ligation and its association with protection from complement. Xenotransplantation 2003, 10:387-397.
59. Nath KA, Balla G, Vercellotti GM, et al.: Induction of heme oxygenase is a rapid, protective response in rhabdomyolysis in the rat. J Clin Invest 1992, 90:267-270.
60. Bach FH, Ferran C, Hechenleitner P, et al.: Accommodation of vascularized xenografts: expression of "protective genes" by donor endothelial cells in a host Th2 cytokine environment. Nat Med 1997, 3:196-204.
61. Soares MP, Lin Y, Anrather J, et al.: Expression of heme oxygenase-1 can determine cardiac xenograft survival. Nat Med 1998, 4:1073-1077.
62. Ihrcke NS, Wrenshall LE, Lindman BJ, et al.: Role of heparan sulfate in immune system-blood vessel interactions. Immunol Today 1993, 14:500-505.
63. Saadi S, Wrenshall LE, Platt JL: Regional manifestations and control of the immune system. FASEB J 2002, 16:849-856.
64. Delikouras A, Fairbanks LD, Simmonds AH, et al.: Endothelial cell cytoprotection induced in vitro by allo- or xenoreactive antibodies is mediated by signaling through adenosine A2 receptors. Eur J Immunol 2003, 33:3127-3135.
65. Park W, Grande JP, Ninova D, et al.: Accommodation in ABO-incompatible kidney allografts, a novel mechanism of self-protection against antibodymediated injury. Am J Transplant 2003, 3:952-960.
66. Tabata T, de Perrot M, Keshavjee S, et al.: Accommodation after lung xenografting from hamster to rat. Transplantation 2003, 75:607-612.
67. Chong AS, Ma LL, Shen J, et al.: Modification of humoral responses by the combination of leflunomide and cyclosporine in Lewis rats transplanted with hamster hearts. Transplantation 1997, 64:1650-1657.